201 related articles for article (PubMed ID: 32069354)
1. USP22 controls iNKT immunity through MED1 suppression of histone H2A monoubiquitination.
Zhang Y; Wang Y; Gao B; Sun Y; Cao L; Genardi SM; Wang CR; Li H; Sun Z; Yang Y; Fang D
J Exp Med; 2020 May; 217(5):. PubMed ID: 32069354
[TBL] [Abstract][Full Text] [Related]
2. Essential role of Mediator subunit Med1 in invariant natural killer T-cell development.
Yue X; Izcue A; Borggrefe T
Proc Natl Acad Sci U S A; 2011 Oct; 108(41):17105-10. PubMed ID: 21949387
[TBL] [Abstract][Full Text] [Related]
3. Effect of Med1 on T cell development and CD4
Zheng H; Jiao A; Liu H; Lei L; Ding R; Feng Z; Zhang D; Zhang L; Zhang B
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Sept 28; 48(9):1296-1303. PubMed ID: 38044640
[TBL] [Abstract][Full Text] [Related]
4. USP22, an hSAGA subunit and potential cancer stem cell marker, reverses the polycomb-catalyzed ubiquitylation of histone H2A.
Zhang XY; Pfeiffer HK; Thorne AW; McMahon SB
Cell Cycle; 2008 Jun; 7(11):1522-4. PubMed ID: 18469533
[TBL] [Abstract][Full Text] [Related]
5. Usp22 deficiency impairs intestinal epithelial lineage specification in vivo.
Kosinsky RL; Wegwitz F; Hellbach N; Dobbelstein M; Mansouri A; Vogel T; Begus-Nahrmann Y; Johnsen SA
Oncotarget; 2015 Nov; 6(35):37906-18. PubMed ID: 26431380
[TBL] [Abstract][Full Text] [Related]
6. β-Catenin is required for the differentiation of iNKT2 and iNKT17 cells that augment IL-25-dependent lung inflammation.
Berga-Bolaños R; Sharma A; Steinke FC; Pyaram K; Kim YH; Sultana DA; Fang JX; Chang CH; Xue HH; Heller NM; Sen JM
BMC Immunol; 2015 Oct; 16():62. PubMed ID: 26482437
[TBL] [Abstract][Full Text] [Related]
7. Aggregation of Polyglutamine-expanded Ataxin 7 Protein Specifically Sequesters Ubiquitin-specific Protease 22 and Deteriorates Its Deubiquitinating Function in the Spt-Ada-Gcn5-Acetyltransferase (SAGA) Complex.
Yang H; Liu S; He WT; Zhao J; Jiang LL; Hu HY
J Biol Chem; 2015 Sep; 290(36):21996-2004. PubMed ID: 26195632
[TBL] [Abstract][Full Text] [Related]
8. Potent macrocycle inhibitors of the human SAGA deubiquitinating module.
Morgan M; Ikenoue T; Suga H; Wolberger C
Cell Chem Biol; 2022 Apr; 29(4):544-554.e4. PubMed ID: 34936860
[TBL] [Abstract][Full Text] [Related]
9. USP22 regulates cell proliferation by deubiquitinating the transcriptional regulator FBP1.
Atanassov BS; Dent SY
EMBO Rep; 2011 Sep; 12(9):924-30. PubMed ID: 21779003
[TBL] [Abstract][Full Text] [Related]
10. USP22 promotes IRF3 nuclear translocation and antiviral responses by deubiquitinating the importin protein KPNA2.
Cai Z; Zhang MX; Tang Z; Zhang Q; Ye J; Xiong TC; Zhang ZD; Zhong B
J Exp Med; 2020 May; 217(5):. PubMed ID: 32130408
[TBL] [Abstract][Full Text] [Related]
11. Regulation of cell cycle progression and gene expression by H2A deubiquitination.
Joo HY; Zhai L; Yang C; Nie S; Erdjument-Bromage H; Tempst P; Chang C; Wang H
Nature; 2007 Oct; 449(7165):1068-72. PubMed ID: 17914355
[TBL] [Abstract][Full Text] [Related]
12. USP22 positively modulates ERα action via its deubiquitinase activity in breast cancer.
Wang S; Zhong X; Wang C; Luo H; Lin L; Sun H; Sun G; Zeng K; Zou R; Liu W; Sun N; Song H; Liu W; Zhang Q; Liao Z; Teng X; Zhou T; Sun X; Zhao Y
Cell Death Differ; 2020 Nov; 27(11):3131-3145. PubMed ID: 32494025
[TBL] [Abstract][Full Text] [Related]
13. TCR signal strength controls thymic differentiation of iNKT cell subsets.
Tuttle KD; Krovi SH; Zhang J; Bedel R; Harmacek L; Peterson LK; Dragone LL; Lefferts A; Halluszczak C; Riemondy K; Hesselberth JR; Rao A; O'Connor BP; Marrack P; Scott-Browne J; Gapin L
Nat Commun; 2018 Jul; 9(1):2650. PubMed ID: 29985393
[TBL] [Abstract][Full Text] [Related]
14. The deubiquitinase USP22 regulates PD-L1 degradation in human cancer cells.
Wang Y; Sun Q; Mu N; Sun X; Wang Y; Fan S; Su L; Liu X
Cell Commun Signal; 2020 Jul; 18(1):112. PubMed ID: 32665011
[TBL] [Abstract][Full Text] [Related]
15. M6A RNA Methylation Regulates Histone Ubiquitination to Support Cancer Growth and Progression.
Yadav P; Subbarayalu P; Medina D; Nirzhor S; Timilsina S; Rajamanickam S; Eedunuri VK; Gupta Y; Zheng S; Abdelfattah N; Huang Y; Vadlamudi R; Hromas R; Meltzer P; Houghton P; Chen Y; Rao MK
Cancer Res; 2022 May; 82(10):1872-1889. PubMed ID: 35303054
[TBL] [Abstract][Full Text] [Related]
16. Transcription factor Bcl11b sustains iNKT1 and iNKT2 cell programs, restricts iNKT17 cell program, and governs iNKT cell survival.
Uddin MN; Sultana DA; Lorentsen KJ; Cho JJ; Kirst ME; Brantly ML; Califano D; Sant'Angelo DB; Avram D
Proc Natl Acad Sci U S A; 2016 Jul; 113(27):7608-13. PubMed ID: 27330109
[TBL] [Abstract][Full Text] [Related]
17. Coupling of T cell receptor specificity to natural killer T cell development by bivalent histone H3 methylation.
Dobenecker MW; Kim JK; Marcello J; Fang TC; Prinjha R; Bosselut R; Tarakhovsky A
J Exp Med; 2015 Mar; 212(3):297-306. PubMed ID: 25687282
[TBL] [Abstract][Full Text] [Related]
18. iNKT subsets differ in their developmental and functional requirements on Foxo1.
Zhang H; Zhang Y; Pan J; Wu Q; Huang Y; Bai S; Tian C; Zhu M; Lian Z; Li F; Tian Z; Bai L
Proc Natl Acad Sci U S A; 2021 Nov; 118(46):. PubMed ID: 34772808
[TBL] [Abstract][Full Text] [Related]
19. The tightly controlled deubiquitination activity of the human SAGA complex differentially modifies distinct gene regulatory elements.
Lang G; Bonnet J; Umlauf D; Karmodiya K; Koffler J; Stierle M; Devys D; Tora L
Mol Cell Biol; 2011 Sep; 31(18):3734-44. PubMed ID: 21746879
[TBL] [Abstract][Full Text] [Related]
20. Med1 Controls Effector CD8
Jiao A; Liu H; Ding R; Zheng H; Zhang C; Feng Z; Lei L; Wang X; Su Y; Yang X; Sun C; Zhang L; Bai L; Sun L; Zhang B
J Immunol; 2022 Sep; 209(5):855-863. PubMed ID: 36130132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]